Skip to content

NOVIL'PHARMA

Absorbed by PHARMACIE VERBORG-PONCELET on 01-03-2019 KBO/BCE: BE 0465.682.350 subsidiary of NOVIL'PHARMA

Lifetime

13 annual accounts with figures on one time axis, 20 filings since 1999
peak of €288,869 in 2018
€288,869▲ 5.4%
peak of €183,386 in 2018
€183,386▲ 6.2%
peak of €747,699 in 2018
€747,699▲ 19.8%
€366,920▼ 7.6%
peak of 1.5 FTE in 2012
0.8 FTEunchanged
Board4 names since 2010
- 
Owners
100%
Documentsfilings and deeds
25-07-20196 days before the deadline
2018financial year
Merger proposal: to be absorbed by PHARMACIE VERBORG-PONCELET 12-11Equity from €624,313 to €747,699

Key points

from the 2018 annual accounts, the last ones filed

Filings

20 annual accounts since 1999
AprilJune31 JulyOctober2000200520102015

Eight of the last ten came late. The 2011 accounts came in latest, 27 days after the end of the period.

Board and ownership

last known board
Managing director, last mentioned in 2017
Director, last mentioned in 2017
  • 100%score equity €744,411 (2025) · deed of 01-03-2019
Board & ownership

Recent changes

Merger: absorbed by PHARMACIE VERBORG-PONCELET PHARMACIE VERBORG-PONCELET holds all the shares · General meeting of 09-01-2019 · Gazette deed
Merger proposal: to be absorbed by PHARMACIE VERBORG-PONCELET acts as permanent representative · PHARMACIE VERBORG-PONCELET holds all the shares · Gazette deed
2 directors reappointed and PHARMACIE VERBORG-PONCELET (managing director) · acts as permanent representative · General meeting of 31-03-2017 · Gazette deed
Company renamed to Novil'Pharma PHARMACIE VERBORG-PONCELET (chair of the board and managing director) and (director) reappointed · appointed as director · acts as permanent representative · General meeting of 25-01-2013 · Gazette deed
All 28 events

Official details

Source: KBO
Status
Absorbed by PHARMACIE VERBORG-PONCELETmerger by absorption, March 2019
Activity
“La société a pour objet toutes opérations se rapportant directement ou indirectement aux produits…” (deed in French)From the articles, 5 activitiesNo NACE code in the KBO
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2018

≈ €690,000estimated
€1.1m
Filing
Filed on 25-07-2019
Financials

Insights on NOVIL'PHARMA

Absorbed by PHARMACIE VERBORG-PONCELET in March 2019. The last annual accounts are for financial year 2018.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about NOVIL'PHARMA

What is the company number of NOVIL'PHARMA?
The company number of NOVIL'PHARMA is 0465.682.350. The VAT number is the same number with BE in front: BE 0465.682.350.
What is the legal form of NOVIL'PHARMA?
Legal form of NOVIL'PHARMA: SA.
Is NOVIL'PHARMA still active?
No. Absorbed in a merger on 01-03-2019.Company details
How many employees did NOVIL'PHARMA have?
NOVIL'PHARMA had an average of 0.8 full-time equivalents in financial year 2018, according to the filed annual accounts.Financials
What is the turnover of NOVIL'PHARMA?
The turnover in financial year 2018 is ≈ €690,000. This figure is estimated from the gross margin of €288,869 and 2,135 comparable companies of the same size. It probably lies between €410,000 and €1.2m. It is a rough estimate.
Is NOVIL'PHARMA profitable?
In financial year 2018, NOVIL'PHARMA made a profit of €183,386.
Where can I find the annual accounts of NOVIL'PHARMA?
NOVIL'PHARMA filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2018.

Next steps

Keep this company with today's facts in a case file.